These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23508615)

  • 21. [Diabetes and the liver].
    Herzig S; Roden M
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1204-6. PubMed ID: 23720171
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity.
    Brevetti G; Schiano V; Sirico G; Giugliano G; Laurenzano E; Chiariello M
    J Vasc Surg; 2006 Jul; 44(1):101-7; discussion 107. PubMed ID: 16753279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between peripheral arterial disease and metabolic syndrome.
    Maksimovic M; Vlajinac H; Radak D; Marinkovic J; Jorga J
    Angiology; 2009; 60(5):546-53. PubMed ID: 19147526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease and cardiovascular disease risk.
    Brown TM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):568-9. PubMed ID: 22387255
    [No Abstract]   [Full Text] [Related]  

  • 25. Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
    Paraskevas KI; Bessias N; Papas TT; Andrikopoulos V; Mikhailidis DP
    Angiology; 2009; 60(1):8-11. PubMed ID: 19190029
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
    Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
    Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NAFLD and cardiovascular risk: direct evidence for the tale of two ages.
    Lonardo A; Loria P
    Am J Gastroenterol; 2009 Jul; 104(7):1851-2. PubMed ID: 19574981
    [No Abstract]   [Full Text] [Related]  

  • 28. Extracoronary atherosclerosis in patients with chronic ischemic heart disease: relationship with risk factors and the severity of coronary artery disease.
    Pipitone S; Corrado E; Muratori I; Novo G; Evola S; Fabbiano A; Trapani R; Zarcone P; Assennato P; Hoffmann E; Novo S
    Int Angiol; 2007 Dec; 26(4):346-52. PubMed ID: 18091702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical applicability of the framingham 30-year risk score. Usefulness in cardiovascular risk stratification and the diagnosis of carotid atherosclerotic plaque].
    Masson W; Siniawski D; Krauss J; Cagide A
    Rev Esp Cardiol; 2011 Apr; 64(4):305-11. PubMed ID: 21377779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease.
    Demircioğlu F; Koçyiğit A; Arslan N; Cakmakçi H; Hizli S; Sedat AT
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):68-75. PubMed ID: 18607271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study.
    Mitchell GF; Vita JA; Larson MG; Parise H; Keyes MJ; Warner E; Vasan RS; Levy D; Benjamin EJ
    Circulation; 2005 Dec; 112(24):3722-8. PubMed ID: 16330686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus and atherosclerosis in a close and dangerous liaison.
    Vassalle C
    Atherosclerosis; 2012 Apr; 221(2):319-20. PubMed ID: 22218226
    [No Abstract]   [Full Text] [Related]  

  • 33. Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis.
    Alkhouri N; Kistangari G; Campbell C; Lopez R; Zein NN; Feldstein AE
    Hepatology; 2012 Jan; 55(1):331. PubMed ID: 21969091
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular phenotype of nonalcoholic fatty liver disease: hanging the paradigm about the role of distant toxic fat accumulation on vascular disease.
    Sookoian S; Castaño GO; Pirola CJ
    Hepatology; 2012 Sep; 56(3):1185-6. PubMed ID: 22505369
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial: Treatment for NASH - helping the liver or helping the heart?
    Armstrong MJ; Newsome PN
    Aliment Pharmacol Ther; 2015 Mar; 41(5):487. PubMed ID: 25631648
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease in developing countries.
    Bahrami H
    World J Gastroenterol; 2005 Jun; 11(24):3808-9. PubMed ID: 15968747
    [No Abstract]   [Full Text] [Related]  

  • 37. Carotid atherosclerosis or nonalcoholic fatty liver disease: which comes first?
    Dogru T; Genc H; Ercin CN
    Atherosclerosis; 2013 Dec; 231(2):187-8. PubMed ID: 24267223
    [No Abstract]   [Full Text] [Related]  

  • 38. Is high leukocyte count synonymous with the presence of endothelial dysfunction or atherosclerosis?
    Koza Y
    Circ J; 2014; 78(4):1009. PubMed ID: 24476802
    [No Abstract]   [Full Text] [Related]  

  • 39. Is high leukocyte count synonymous with the presence of endothelial dysfunction or atherosclerosis?
    Li J; Lerman A
    Circ J; 2014; 78(4):1010. PubMed ID: 24476803
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of angulation at stent edge and plaque increase or negative remodeling.
    Yamaguchi H; Atsuchi Y; Kaneda H
    Circ J; 2014; 78(4):1011. PubMed ID: 24572489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.